Today’s Screen of the Day features four institutional-quality drug and medical Big Caps stocks with solid fundamentals. Jazz Pharmaceuticals (JAZZ), which has a market cap of $9.85 billion, earned an IBD Composite Rating of 99, which means that it has outperformed 99% of all stocks in key metrics such as earnings and sales. Best-selling narcolepsy medication Xyrem made up two-thirds of Jazz’s second-quarter sales. The company acquired Italian
With the market in a confirmed uptrend, it’s time to take a hard look at highly-rated stocks on the move. IBD’s Screen Of The Day is Bolting RS Lines — stocks such as BitAuto (BITA) — whose stock price’s relative strength is surging vs. the S&P 500 index. The screen includes five companies that mutual funds, insurance and pension funds are rapidly accumulating. Here are the top five stocks with rapidly rising RS lines that have an excellent
Solid fundamentals are the signs of a solid stock. Today’s Screen of the Day features companies with Top Fundamentals. These firms have three-year earnings and growth rates of at least 25% or higher, including Chinese stock YY (YY) and others. YY, an online social platform that lets users engage in shared activities on the Web, has a three-year earnings-per-share growth rate of 300%. It’s a Screen of the Day regular with its rising estimates and